| R11850 |
TUBERCIDIN |
N/A
|
| R11852 |
sutezolid |
N/A
|
| R11853 |
AE38;AVex-73 |
AVex-73 is a muscarinic M1 agonist and a moderate sigma1 receptor potentially fo
|
| R11861 |
2-methyladenosine |
N/A
|
| R11862 |
4-Methyl-5,7-dihydroxyisobenzofuran-1(3H)-one |
N/A
|
| R11863 |
I-BET151 (Synonyms: GSK1210151A) |
I-BET151 is a BET bromodomain inhibitor which inhibits BRD4, BRD2, and BRD3 with
|
| R11864 |
UNC1999 |
UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH1/2 with IC50
|
| R11866 |
ARV-825 |
ARV-825 is a BRD4 degrader based on PROTAC technology. ARV-825 binds t
|
| R11867 |
BAY 61-3606 |
BAY 61-3606 is an orally available, ATP-competitive, reversible and highly selec
|
| R11868 |
Takinib |
Takinib is a potent and selective TAK1 inhibitor with an IC50 of 9.5 nM, which i
|
| R11870 |
UNC0321 |
UNC0321 is a potent and selective G9a inhibitor with Ki of 63 pM, UNC0321 is the
|
| R11872 |
GNE-317 |
GNE-317 is a PI3K/mTOR inhibitor, is able to cross the blood-brain bar
|
| R11873 |
Salubrinal |
Salubrinal is a cell-permeable and selective inhibitor of eIF2α dephosphory
|
| R11874 |
YU238259 |
YU238259 is an inhibitor of homology-dependent DNA repair (HDR), used for cancer
|
| R11875 |
Salermide |
Salermide is an inhibitor of Sirt1 and Sirt2; can cause strong ca
|
| R11876 |
Tideglusib (Synonyms: NP031112) |
Tideglusib (NP031112) is an irreversible GSK-3 inhibitor with IC50s of 5 nM and
|
| R11877 |
Rabusertib (Synonyms: LY2603618; IC-83) |
Rabusertib (LY2603618) is a potent and selective inhibitor of Chk1 with an IC50
|
| R11878 |
Aloxistatin (E64d) |
Aloxistatin (E64d) is a cell-permeable and irreversible broad-spectrum cyst
|
| R11879 |
E-64C |
N/A
|
| R11880 |
Saccharin 1-methylimidazole (SMI) |
Saccharin 1-methylimidazole is an activator for DNA/RNA Synthesis.
|
| R11881 |
CeMMEC1 |
CeMMEC1 is an inhibitor of BRD4, and also has high affinity for TAF1,
|
| R11882 |
JZL184 |
JZL 184 is a potent, selective and irreversible monoacylglycerol lipas
|
| R11883 |
KML-29 |
KML29 is a potent and selective MAGL inhibitor with IC50 = 5.9, 15, and 43 nM in
|
| R11884 |
Sapanisertib (INK-128; MLN0128; TAK-228) |
Sapanisertib (INK-128; MLN0128; TAK-228) is an orally available, ATP-dependent&n
|
| R11885 |
(S,R,S)-AHPC hydrochloride (MDK7526 hydrochloride) |
(S,R,S)-AHPC hydrochloride (MDK7526 hydrochloride) is the VH032-based VHL ligand
|